NCT00076856View on ClinicalTrials.gov

Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)

PHASE2CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Carcinoma, Non-Small-Cell LungNeoplasm MetastasisBrain Neoplasms
Interventions
DRUG

Temozolomide

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00076856 - Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247) | Biotech Hunter | Biotech Hunter